BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Inotrem Successfully Reaches Agreement with the FDA for a Phase 3 Registration Trial for Nangibotide in Septic Shock

  Inotrem announced the outcome of its regulatory interactions with the US Food and Drug Administration to finalize the design of a single Phase 3 registration trial for nangibotide in septic shock.

  January 8, 2024

   · 

  4 min read
• Deals

  Calibre Scientific Expands Assisted Reproductive Technologies Portfolio With Strategic Acquisitions of Scopescreen and Microm UK Limited

  Calibre Scientific is pleased to announce the acquisitions of Microm UK Limited and Scopescreen, LLC, further solidifying its commitment to reproductive health and testing.

  January 8, 2024

   · 

  3 min read
• Business

  NanoPhoria appoints Dr. Suman Shirodkar as Chair and Prof. Michael Davidson as Non-Executive Member of the Board of Directors

  NanoPhoria announced two key board appointments as it continues to build a versatile and experienced team.

  January 8, 2024

   · 

  4 min read
• Drug Development

  HighField Biopharmaceuticals HF1K16 Phase 1a Data Suggests the New Immuno-Oncology Drug is Safe, Well-Tolerated and Efficacious in Solid Tumors

  HighField Biopharmaceuticals, a clinical stage immuno-oncology company using lipid-based therapeutics to treat cancer, announced it has completed its Phase 1a study of HF1K16.

  January 8, 2024

   · 

  2 min read
• Biotech Beach

  RadNet, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 10th, 2024

  RadNet, Inc. announced that Dr. Howard Berger, President and Chief Executive Officer and Mark Stolper, Executive Vice President and Chief Financial Officer will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 10, 2024 at 4:30 p.m. PST.

  January 8, 2024

   · 

  1 min read
• Business

  Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance

  Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, announced financial guidance for full year 2024.

  January 8, 2024

   · 

  13 min read
• Business

  Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO

  Zura Bio Limited announced the appointments of Robert Lisicki as President and Chief Operating Officer, and Kiran Nistala, MBBS, PhD, as Executive Vice President Development and Chief Medical Officer, to the Executive Leadership Team.

  January 8, 2024

   · 

  8 min read
• FluoGuide Provides Strategic Update and Outlines Development Plans Towards Commercialization of FG001

  FluoGuide A/S is pleased to provide an update on its corporate strategy and plans for further clinical development and commercialization of its lead product FG001.

  January 8, 2024

   · 

  7 min read
• Pharm Country

  SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference

  SpringWorks Therapeutics, Inc. will present at the 42nd Annual J.P. Morgan Healthcare Conference at 7:30 a.m. PT, and a live webcast will be available at ir.springworkstx.com.

  January 8, 2024

   · 

  12 min read
• Business

  Caris Life Sciences and Flatiron Health Partner to Create Transformational Real-World Data Offering

  Caris Life Sciences® and Flatiron Health announced a partnership to create a multimodal data offering to support and accelerate biopharmaceutical drug development and patient care.

  January 8, 2024

   · 

  4 min read